Haier Consolidates Its Position as One of the Most Valuable Global Brands and the Only IoT Ecosystem Brand in the World
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
Sun Life posts rise in quarterly profit on strong Asia-unit performance
Canada's Sun Life Financial SLF-T reported a jump in second-quarter profit on Thursday, driven by strong growth in its Asia unit, where insurers are expanding to tap a growing, underinsured middle class and offset weakness in the U.S. market. 'Sun Life's Q2 results were driven by record underlying net income in Asia with strong protection business growth, higher wealth management and investment earnings,' CEO Kevin Strain said in a statement. Underlying net income from the company's Asia operations helped lift overall earnings to $716 million, or $1.26 per share, for the quarter ended June 30, up from $646 million, or $1.11 per share, a year earlier. However, underlying earnings from its individual protection business declined 10% to $299 million. An AI app is helping diabetics count carbs with photos of their food – and major health care insurers are buying in Underlying earnings from its group health and protection business rose 7% to $326 million, while individual protection earnings fell 10% to $299 million. Wealth and asset management income was flat at $455 million. The Toronto-based company reported underlying EPS of $1.79, compared with analysts' average estimate of $1.78 per share, according to LSEG data. Underlying earnings from Sun Life Financial's group health and protection businesses, which provide insurance policies to employer and government plan members, rose 7% to $326 million. Sun Life also said David Healy will become President of Sun Life U.S. effective Sept. 1, 2025, succeeding Dan Fishbein, who plans to retire in March 2026. Shares of Sun Life have declined about 1% this year, while rival Manulife MFC-T, which also reported strong Asia growth this week, is down 6.4%.
Globe and Mail
2 hours ago
- Globe and Mail
MSCI Equity Indexes August 2025 Index Review
MSCI Inc. announced the results of the August 2025 Index Review for the MSCI Equity Indexes. All changes will be implemented as of the close of August 26, 2025. Highlights include: MSCI Global Standard Indexes: Forty-two securities will be added to and 56 securities will be deleted from the MSCI ACWI Index. The three largest additions to the MSCI World Index measured by full company market capitalization will be Rocket Lab Corp (USA), SoFi Technologies (USA) and Affirm Holdings A (USA). The three largest additions to the MSCI Emerging Markets Index measured by full company market capitalization will be China CITIC Bank A (HK-C) (China), Dian Swastatika Sentosa (Indonesia) and Laopu Gold H (China). MSCI Global Small Cap Indexes: There will be 194 additions to and 107 deletions from the MSCI ACWI Small Cap Index. MSCI Global Investable Market Indexes: There will be 176 additions to and 103 deletions from the MSCI ACWI Investable Market Index (IMI). MSCI Global All Cap Indexes: There will be 120 additions to and 60 deletions from the MSCI World All Cap Index. MSCI Frontier Markets Indexes: There will be nine additions to and four deletions from the MSCI Frontier Markets Index. The three largest additions to the MSCI Frontier Markets Index measured by full company market capitalization will be FPT Corp (Vietnam), Asyad Shipping Company (Oman) and Société Générale de Banques en Côte d'Ivoire (Ivory Coast). There will be 28 additions to and 11 deletions from the MSCI Frontier Markets Small Cap Index. In light of currently observed market accessibility issues, MSCI will continue to not implement changes as part of this Index Review for any securities classified in Bangladesh for the MSCI Bangladesh Indexes or impacted composite indexes. These changes, along with other changes across MSCI Equity Indexes including the MSCI US Equity Indexes, MSCI US REIT Index, MSCI China A Onshore Indexes and China All Shares Indexes are available on MSCI's "Index Review" web page: -Ends- About MSCI MSCI Inc. (NYSE: MSCI) strengthens global markets by connecting participants across the financial ecosystem with a common language. Our research-based data, analytics and indexes, supported by advanced technology, set standards for global investors and help our clients understand risks and opportunities so they can make better decisions and unlock innovation. We serve asset managers and owners, private-market sponsors and investors, hedge funds, wealth managers, banks, insurers and corporates. To learn more, please visit Media Inquiries PR@ Melanie Blanco +1 212 981 1049 Konstantinos Makrygiannis +44 77 6893 0056 Tina Tan +852 2844 9320 MSCI Global Client Service EMEA Client Service + 44 20 7618 2222 Americas Client Service +1 888 588 4567 Asia Pacific Client Service + 852 2844 9333 This document and all of the information contained in it, including without limitation all text, data, graphs, charts (collectively, the 'Information') is the property of MSCI Inc. or its subsidiaries (collectively, 'MSCI'), or MSCI's licensors, direct or indirect suppliers or any third party involved in making or compiling any Information (collectively, with MSCI, the 'Information Providers') and is provided for informational purposes only. The Information may not be modified, reverse-engineered, reproduced or redisseminated in whole or in part without prior written permission from MSCI. All rights in the Information are reserved by MSCI and/or its Information Providers. The Information may not be used to create derivative works or to verify or correct other data or information. For example (but without limitation), the Information may not be used to create indexes, databases, risk models, analytics, software, or in connection with the issuing, offering, sponsoring, managing or marketing of any securities, portfolios, financial products or other investment vehicles utilizing or based on, linked to, tracking or otherwise derived from the Information or any other MSCI data, information, products or services. The user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. NONE OF THE INFORMATION PROVIDERS MAKES ANY EXPRESS OR IMPLIED WARRANTIES OR REPRESENTATIONS WITH RESPECT TO THE INFORMATION (OR THE RESULTS TO BE OBTAINED BY THE USE THEREOF), AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, EACH INFORMATION PROVIDER EXPRESSLY DISCLAIMS ALL IMPLIED WARRANTIES (INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF ORIGINALITY, ACCURACY, TIMELINESS, NON-INFRINGEMENT, COMPLETENESS, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT TO ANY OF THE INFORMATION. Without limiting any of the foregoing and to the maximum extent permitted by applicable law, in no event shall any Information Provider have any liability regarding any of the Information for any direct, indirect, special, punitive, consequential (including lost profits) or any other damages even if notified of the possibility of such damages. The foregoing shall not exclude or limit any liability that may not by applicable law be excluded or limited, including without limitation (as applicable), any liability for death or personal injury to the extent that such injury results from the negligence or willful default of itself, its servants, agents or sub-contractors. Information containing any historical information, data or analysis should not be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. Past performance does not guarantee future results. The Information may include 'Signals,' defined as quantitative attributes or the product of methods or formulas that describe or are derived from calculations using historical data. Neither these Signals nor any description of historical data are intended to provide investment advice or a recommendation to make (or refrain from making) any investment decision or asset allocation and should not be relied upon as such. Signals are inherently backward-looking because of their use of historical data, and they are not intended to predict the future. The relevance, correlations and accuracy of Signals frequently will change materially. The Information should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. All Information is impersonal and not tailored to the needs of any person, entity or group of persons. None of the Information constitutes an offer to sell (or a solicitation of an offer to buy), any security, financial product or other investment vehicle or any trading strategy. It is not possible to invest directly in an index. Exposure to an asset class or trading strategy or other category represented by an index is only available through third party investable instruments (if any) based on that index. MSCI does not issue, sponsor, endorse, market, offer, review or otherwise express any opinion regarding any fund, ETF, derivative or other security, investment, financial product or trading strategy that is based on, linked to or seeks to provide an investment return related to the performance of any MSCI index (collectively, 'Index Linked Investments'). MSCI makes no assurance that any Index Linked Investments will accurately track index performance or provide positive investment returns. MSCI Inc. is not an investment adviser or fiduciary and MSCI makes no representation regarding the advisability of investing in any Index Linked Investments. Index returns do not represent the results of actual trading of investible assets/securities. MSCI maintains and calculates indexes, but does not manage actual assets. The calculation of indexes and index returns may deviate from the stated methodology. Index returns do not reflect payment of any sales charges or fees an investor may pay to purchase the securities underlying the index or Index Linked Investments. The imposition of these fees and charges would cause the performance of an Index Linked Investment to be different than the MSCI index performance. The Information may contain back tested data. Back-tested performance is not actual performance, but is hypothetical. There are frequently material differences between back tested performance results and actual results subsequently achieved by any investment strategy. Constituents of MSCI equity indexes are listed companies, which are included in or excluded from the indexes according to the application of the relevant index methodologies. Accordingly, constituents in MSCI equity indexes may include MSCI Inc., clients of MSCI or suppliers to MSCI. Inclusion of a security within an MSCI index is not a recommendation by MSCI to buy, sell, or hold such security, nor is it considered to be investment advice. Data and information produced by various affiliates of MSCI Inc., including MSCI ESG Research LLC and Barra LLC, may be used in calculating certain MSCI indexes. More information can be found in the relevant index methodologies on MSCI receives compensation in connection with licensing its indexes to third parties. MSCI Inc.'s revenue includes fees based on assets in Index Linked Investments. Information can be found in MSCI Inc.'s company filings on the Investor Relations section of MSCI ESG Research LLC is a Registered Investment Adviser under the Investment Advisers Act of 1940 and a subsidiary of MSCI Inc. Neither MSCI nor any of its products or services recommends, endorses, approves or otherwise expresses any opinion regarding any issuer, securities, financial products or instruments or trading strategies and MSCI's products or services are not a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such, provided that applicable products or services from MSCI ESG Research may constitute investment advice. MSCI ESG Research materials, including materials utilized in any MSCI ESG Indexes or other products, have not been submitted to, nor received approval from, the United States Securities and Exchange Commission or any other regulatory body. MSCI ESG and climate ratings, research and data are produced by MSCI ESG Research LLC, a subsidiary of MSCI Inc. MSCI ESG Indexes, Analytics and Real Estate are products of MSCI Inc. that utilize information from MSCI ESG Research LLC. MSCI Indexes are administered by MSCI Limited (UK) and MSCI Deutschland GmbH. Please note that the issuers mentioned in MSCI ESG Research materials sometimes have commercial relationships with MSCI ESG Research and/or MSCI Inc. (collectively, 'MSCI') and that these relationships create potential conflicts of interest. In some cases, the issuers or their affiliates purchase research or other products or services from one or more MSCI affiliates. In other cases, MSCI ESG Research rates financial products such as mutual funds or ETFs that are managed by MSCI's clients or their affiliates, or are based on MSCI Inc. Indexes. In addition, constituents in MSCI Inc. equity indexes include companies that subscribe to MSCI products or services. In some cases, MSCI clients pay fees based in whole or part on the assets they manage. MSCI ESG Research has taken a number of steps to mitigate potential conflicts of interest and safeguard the integrity and independence of its research and ratings. More information about these conflict mitigation measures is available in our Form ADV, available at Any use of or access to products, services or information of MSCI requires a license from MSCI. MSCI, Barra, RiskMetrics, IPD and other MSCI brands and product names are the trademarks, service marks, or registered trademarks of MSCI or its subsidiaries in the United States and other jurisdictions. The Global Industry Classification Standard (GICS) was developed by and is the exclusive property of MSCI and S&P Dow Jones Indices. 'Global Industry Classification Standard (GICS)' is a service mark of MSCI and S&P Dow Jones Indices. MIFID2/MIFIR notice: MSCI ESG Research LLC does not distribute or act as an intermediary for financial instruments or structured deposits, nor does it deal on its own account, provide execution services for others or manage client accounts. No MSCI ESG Research product or service supports, promotes or is intended to support or promote any such activity. MSCI ESG Research is an independent provider of ESG data.
National Post
5 hours ago
- National Post
Jamieson Wellness Inc. Reports Second Quarter 2025 Results
Article content TORONTO — Jamieson Wellness Inc. ('Jamieson Wellness' or the 'Company') (TSX: JWEL) today reported its second quarter results for the period ended June 30, 2025. All amounts are expressed in Canadian dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other financial measures. See 'Non-IFRS and Other Financial Measures' below. Article content Management Commentary 'Q2 marked another solid quarter, reinforcing the continued strength of the health and wellness category and Jamieson's leadership within it,' said Mike Pilato, President and CEO of Jamieson Wellness. 'Branded revenue growth of nearly 14 percent reflects both sustained global demand for our trusted brands and our team's precise execution of our strategic plan across all key markets. Article content 'In Canada, our 'Proudly Canadian' platform continues to resonate with consumers driving strong consumption growth while our innovation pipeline drives category-leading performance. In the U.S., youtheory is gaining traction through our traditional retail presence and our new ecommerce partnership, with strong consumption growth validating our strategy. In China, our successful 6/18 campaign delivered exceptional growth as our investment in brand awareness continues to resonate with consumers. And internationally, we're seeing continued momentum driven by innovation, particularly across the Middle East and Southeast Asia. Article content 'In the first half of 2025, our branded business expanded by nearly 14%, with growth across all our branded business units. As we head into the second half of the year we're pleased to increase our quarterly dividend, as we have done every year as a public company. We remain focused on executing our innovation roadmap, expanding our global reach, and driving operational excellence. Built on our 103-year foundation of quality and trust, we're executing from an even stronger position as we continue to Inspire Better Lives Every Day.' Second Quarter Highlights Article content New Jamieson innovation, notably behind the trending magnesium category and 'Proudly Canadian' marketing programs drove strong consumer consumption in Canada Highly successful 6/18 promotion in China achieved 73% growth over prior year Trending ingredients drove increased youtheory consumption including accelerated growth in stress support and a market-leading product in the energy category New product launches and successful heart and women's health campaigns drove sell through in many International markets Article content Summary of Consolidated Results Article content All comparisons are with the second quarter of 2024 Article content Consolidated revenue increased 7.7% to $199.1 million, driven by 13.8% growth in Jamieson Brands partially offset by an expected decline in Strategic Partners Gross profit increased by $15.8 million to $80.8 million; normalized gross profit increased by $14.2 million largely driven by higher branded revenue and margins Gross profit margin 3 increased by 540 basis points; normalized gross profit margin increased 460 basis points due to favourable channel mix and prior year inefficiencies EBITDA 1 increased by $5.8 million to $30.1 million, mainly driven by higher revenues and gross profit; Adjusted EBITDA 1 increased by $3.5 million or 11.2% to $35.1 million, reflecting the impact of higher sales volumes, partially offset by timing of investments in SG&A Net earnings was $13.8 million; Adjusted net earnings 1 was $17.3 million, or $2.6 million higher, reflecting higher normalized earnings from operations Diluted earnings per share was $0.30; Adjusted diluted earnings per share 2 was $0.40 Article content Summary of Segment Results Article content Jamieson Brands Article content Revenue increased 13.8% or $21.5 million Canada revenue increased by 2.0%, driven by strong consumer consumption, partially offset by the impact of order fulfillment in Q2 prior year after the labour disruption in the first quarter China revenue increased 70.8% driven by a successful 6/18 promotional campaign, continued brand loyalty growth behind our brand building investment, and a heavier weighting of influencer programs scheduled in the quarter youtheory revenue increased by 9.7% mainly driven by strong consumption in e-commerce driven by our new strategic partnership, growth in our traditional channels, and timing of shipments of our Q3 promotional programs International revenue increased by 9.6% driven by growth in core markets in the Middle East and Asia Gross profit increased by $17.0 million to $78.3 million; normalized gross profit increased by $15.4 million mainly driven by revenue growth and higher margins Gross profit margin 3 increased by 480 basis points; normalized gross profit margin increased by 370 basis points mainly driven by volume efficiencies compared to inefficiencies due to the labour disruption in the prior year and favourable channel mix Adjusted EBITDA 1 increased by $4.8 million to $33.5 million, driven by higher gross profit partially offset by timing of SG&A to support growth and brand awareness in China; Adjusted EBITDA margin 2 was 18.9%, an increase of 50 basis points mainly due to improved gross profit margins Article content Strategic Partners Article content Revenue decreased an expected 24.9% or $7.2 million, impacted by the timing of customer ordering patterns under new programs and shipments shifting to the second half of the year Gross profit decreased by $1.2 million; gross profit margin 3 decreased by 110 basis points driven mainly by production mix Adjusted EBITDA 1 was $1.6 million, a decrease of $1.2 million; Adjusted EBITDA margin 2 was 7.5%, a decrease of 240 basis points Article content Balance Sheet and Cash Flow from Operations Article content All comparisons are with the second quarter of 2024 Article content As at June 30, 2025, the Company had approximately $132.9 million in cash and available revolving and swingline facilities and net debt 1 of $367.1 million The Company generated $11.4 million in cash from operations compared to $6.9 million generated in Q2 2024 Cash from operating activities before working capital considerations of $18.8 million was $1.7 million higher than Q2 2024 Cash invested in working capital decreased by $2.9 million mainly due to timing of vendor payments, partially offset by the timing of customer collections and increased inventories to support the growth of the business During the six-month period ended June 30, 2025, the Company purchased for cancellation 444,580 Common Shares under its normal course issuer bid ('NCIB') program for an aggregate consideration of $13.1 million Article content 1 This is a non-IFRS financial measure. See the 'Non-IFRS and Other Financial Measures' section of this press release for more information on each non-IFRS financial measure. 2 This is a non-IFRS ratio. See the 'Non-IFRS and Other Financial Measures' section of this press release for more information on each non-IFRS ratio. 3 This is a supplementary financial measure. See the 'Non-IFRS and Other Financial Measures' section of this press release for more information on each supplementary financial measure. Article content Adjusting Fiscal 2025 Outlook Article content The Company is maintaining its consolidated revenue and Adjusted EBITDA outlook for the 2025 fiscal year and continues to anticipate the following: Article content The Company is adjusting its outlook for the 2025 fiscal year to reflect higher Jamieson Brands revenue in China due to strong demand, and lower Strategic Partners revenue to account for the timing of onboarding new partners. As such, the Company now expects the following: Article content Revenue in the Jamieson Brands segment to range between $695.0 to $725.0 (10.5% to 15.3% growth), updated from the Company's previous expectation of $685.0 to $720.0 million (9.0% to 14.5% growth) Jamieson China revenue to grow 30.0% to 40.0%, updated from the previous range of 25.0% to 35.0%. Growth will be driven by market growth, innovation, and by further extending effectiveness and efficiency within digital programs driving trial and awareness. Revenue in the Strategic Partners segment to range between $105.0 to $116.0 (up to 10.0% growth), updated from the Company's previous expectation of $116.0 to $121.0 million (10.0% to 15.0% growth) Growth is expected to be driven by new programs and industry growth propelling higher volumes within the Company's existing program portfolio. Uncertainties surrounding U.S. tariffs have delayed launches of new programs and the timing of onboarding new customers have shifted revenues to the following year. Article content In addition, Adjusted diluted earnings per share is expected to range from $1.79 to $1.90 (11.0% to 18.0% growth), reflecting higher interest expense on the repurchase of shares under the NCIB program and timing of seasonal working capital investments. Article content The Company's 2025 guidance reflects the current prevailing trade environment between the United States, Canada and other countries. To date, tariffs have not had a material impact on the Company's overall financial performance, as these costs have been mitigated through the Company's flexible supply chain and operating efficiencies. The Company recognizes that the trade environment is constantly changing and actual results may be impacted by future changes in global trade policies. For additional details on the Company's fiscal 2025 outlook, including guidance for the third quarter of 2025, refer to the 'Outlook' section in the management's discussion and analysis of financial condition and results of operations ('MD&A') for the three and six months ended June 30, 2025. Article content Declaration of Second Quarter Dividend Article content The board of directors of the Company authorized a 2.0 cent or a 9.5% increase in the quarterly dividend and declared a cash dividend for the second quarter of 2025 of $0.23 per common share, or approximately $9.5 million in total. Article content Payable: September 12, 2025 Record date: August 29, 2025 Designated an 'eligible dividend' under the Income Tax Act (Canada) Article content The Company's unaudited condensed consolidated interim financial statements and accompanying notes as at and for the three and six months ended June 30, 2025 and related MD&A are available under the Company's profile on SEDAR+ at and on the Investor Relations section of the Company's website at Article content Conference Call Article content Management will host a conference call to discuss the Company's second quarter 2025 results at 5:00 p.m. ET today, August 7, 2025. To access: Article content About Jamieson Wellness Article content Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada's #1 vitamins, minerals and supplements ('VMS') brand. The Company's youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also offers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information please visit Article content Jamieson Wellness' head office is located at 1 Adelaide Street East Suite 2200, Toronto, Ontario, Canada. Article content Forward-Looking Information Article content This press release may contain forward-looking information within the meaning of applicable securities legislation. Such information includes, but is not limited to, statements related to the Company's anticipated results and its outlook for its 2024 revenue, Adjusted EBITDA and Adjusted diluted earnings per share. Words such as 'expect', 'anticipate', 'intend', 'may', 'will', 'estimate' and variations of such words and similar expressions are intended to identify such forward-looking information. This information reflects the Company's current expectations regarding future events. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond the Company's control that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to, the factors discussed under 'Risk Factors' in the Company's Annual Information Form dated March 31, 2025 and under the 'Risk Factors' section in the MD&A filed today, August 7, 2025. This information is based on the Company's reasonable assumptions and beliefs in light of the information currently available to it and the statements are made as of the date of this press release. The Company does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law or regulatory authority. Article content The Company cautions that the list of risk factors and uncertainties is not exhaustive and other factors could also adversely affect the Company's results. Readers are urged to consider the risks, uncertainties and assumptions associated with these statements carefully in evaluating the forward-looking information and are cautioned not to place undue reliance on such information. See 'Forward-looking Information' and 'Risk Factors' within the MD&A for a discussion of the uncertainties, risks and assumptions associated with these statements. Article content Jamieson Wellness Inc. Selected Consolidated Financial Information In thousands of Canadian dollars, except share and per share amounts Three months ended Six months ended June 30 June 30 2025 2024 2025 2024 Revenue 199,109 184,806 345,072 312,844 Cost of sales 118,295 119,778 209,038 205,031 Gross profit 80,814 65,028 136,034 107,813 Gross profit margin 40.6 % 35.2 % 39.4 % 34.5 % Selling, general and administrative expenses 55,346 43,867 104,933 83,425 Share-based compensation 2,078 1,744 4,165 3,493 Earnings from operations 23,390 19,417 26,936 20,895 Operating margin 11.7 % 10.5 % 7.8 % 6.7 % Foreign exchange gain (1,749 ) (180 ) (1,245 ) (951 ) Interest expense and other financing costs 4,771 4,647 9,679 9,520 Accretion on preferred shares 1,155 2,121 3,427 4,340 Earnings before income taxes 19,213 12,829 15,075 7,986 Provision for income taxes 5,385 4,516 3,761 3,392 Net earnings 13,828 8,313 11,314 4,594 Net earnings attributable to: Shareholders 13,071 8,653 10,625 4,540 Non-controlling interests 757 (340 ) 689 54 13,828 8,313 11,314 4,594 Adjusted net earnings 17,267 14,654 23,215 18,569 EBITDA 30,118 24,358 37,915 31,507 Adjusted EBITDA 35,100 31,555 54,166 47,652 Adjusted EBITDA margin 17.6 % 17.1 % 15.7 % 15.2 % Weighted average number of shares Basic 41,712,207 41,456,594 41,845,278 41,468,227 Diluted 43,065,916 42,472,623 43,104,101 42,304,411 Earnings per share attributable to common shareholders: Basic, earnings per share 0.31 0.20 0.25 0.11 Diluted, earnings per share 0.30 0.20 0.25 0.11 Adjusted diluted, earnings per share 0.40 0.35 0.54 0.44 Article content Jamieson Wellness Inc. Consolidated Statements of Financial Position In thousands of Canadian dollars June 30, 2025 December 31, 2024 Assets Current assets Cash 50,537 44,787 Accounts receivable 165,085 228,031 Inventories 191,939 154,658 Derivatives 1,238 2,661 Prepaid expenses and other current assets 6,167 6,803 Income taxes recoverable 5,272 – 420,238 436,940 Non-current assets Property, plant and equipment 101,302 103,591 Goodwill 279,433 287,503 Intangible assets 364,747 377,214 Deferred income tax 4,265 3,545 Total assets 1,169,985 1,208,793 Liabilities Current liabilities Accounts payable and accrued liabilities 139,102 137,653 Income taxes payable 1,345 4,373 Derivatives 4,767 2,982 Current portion of other long-term liabilities 17,790 27,673 163,004 172,681 Long-term liabilities Long-term debt 417,652 308,285 Post-retirement benefits 1,268 1,209 Deferred income tax 63,594 64,467 Redeemable preferred shares – 98,138 Other long-term liabilities 13,409 15,633 Total liabilities 658,927 660,413 Equity Share capital 328,879 326,219 Warrants 14,705 14,705 Contributed surplus 25,014 23,835 Retained earnings 82,436 99,109 Accumulated other comprehensive income 17,336 41,313 Total shareholders' equity 468,370 505,181 Non-controlling interests 42,688 43,199 Total equity 511,058 548,380 Total liabilities and equity 1,169,985 1,208,793 Article content Non-IFRS and Other Financial Measures Article content This press release makes reference to certain financial measures, including non-IFRS financial measures that are historical, non-IFRS measures that are forward-looking, non-GAAP ratios and supplementary financial measures. Management uses these financial measures for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the profitability of ongoing operations and in analyzing the Company's business performance and trends. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company's results of operations from management's perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the Company's financial information reported under IFRS. The Company uses the following non-IFRS financial measures: 'EBITDA', 'Adjusted EBITDA' and 'Adjusted net earnings', the most directly comparable financial measure for each that is disclosed in its financial statements being net earnings, 'normalized gross profit', 'normalized SG&A', 'normalized earnings from operations', 'cash from operating activities before working capital considerations' and 'net debt', the most directly comparable financial measures for each that is disclosed in its financial statements being gross profit, SG&A, earnings from operations, cash flows from operating activities, and long-term debt, respectively, the following non-IFRS ratios: 'Adjusted EBITDA margin', 'Adjusted diluted earnings per share', 'normalized gross profit margin', 'normalized operating margin', and the following supplementary financial measures: 'gross profit margin' and 'operating margin' to provide supplemental measures of the Company's operating performance and thus highlight trends in the Company's core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management also uses non-IFRS and supplementary financial measures in order to prepare annual operating budgets and to determine components of management compensation. For an explanation of the composition of each such measure and the usefulness and additional uses of each by management, see the 'How we Assess the Performance of our Business' section of the MD&A, which is incorporated by reference. See below for a quantitative reconciliation of each non-IFRS financial measure to its most directly comparable financial measure disclosed in the Company's financial statements to which the measure relates. Article content The following tables provide a quantitative reconciliation of net earnings to EBITDA, Adjusted EBITDA, and Adjusted net earnings, as well as gross profit to normalized gross profit, SG&A to normalized SG&A, earnings from operations to normalized earnings from operations and net debt, each of which are non-IFRS financial measures (see the 'Non-IFRS and Other Financial Measures' of this press release for further information on each non-IFRS financial measure) for the three and six months ended June 30, 2025. Article content Jamieson Wellness Inc. Three months ended June 30 2025 2024 $ Change % Change Revenue 177,317 155,787 21,530 13.8 % Gross profit 78,251 61,284 16,967 27.7 % Labour relations costs (1) – 1,414 (1,414 ) (100.0 %) Acquisition and divestiture related costs (2) – 165 (165 ) (100.0 %) Normalized gross profit 78,251 62,863 15,388 24.5 % Gross profit margin 44.1 % 39.3 % – 4.8 % Normalized gross profit margin 44.1 % 40.4 % – 3.7 % Share-based compensation (3) 2,078 1,744 334 19.2 % Selling, general and administrative expenses 53,767 42,262 11,505 27.2 % Acquisition and divestiture related costs (2) – (324 ) 324 100.0 % IT system implementation (4) (3,796 ) (3,449 ) (347 ) (10.1 %) Legal and other (6) (857 ) – (857 ) (100.0 %) Labour relations costs (1) – (281 ) 281 100.0 % Normalized selling, general and administrative expenses 49,114 38,208 10,906 28.5 % Earnings from operations 22,406 17,278 5,128 29.7 % Acquisition and divestiture related costs (2) – 489 (489 ) (100.0 %) IT system implementation (4) 3,796 3,449 347 10.1 % Labour relations costs (1) – 1,695 (1,695 ) (100.0 %) Legal and other (6) 857 – 857 100.0 % Normalized earnings from operations 27,059 22,911 4,148 18.1 % Operating margin 12.6 % 11.1 % – 1.5 % Normalized operating margin 15.3 % 14.7 % – 0.6 % Adjusted EBITDA 33,455 28,691 4,764 16.6 % Adjusted EBITDA margin 18.9 % 18.4 % – 0.5 % Strategic Partners Three months ended June 30 2025 2024 $ Change % Change Revenue 21,792 29,019 (7,227 ) (24.9 %) Gross profit 2,563 3,744 (1,181 ) (31.5 %) Gross profit margin 11.8 % 12.9 % – (1.1 %) Selling, general and administrative expenses 1,579 1,605 (26 ) (1.6 %) Earnings from operations 984 2,139 (1,155 ) (54.0 %) Operating margin 4.5 % 7.4 % – (2.9 %) Adjusted EBITDA 1,645 2,864 (1,219 ) (42.6 %) Adjusted EBITDA margin 7.5 % 9.9 % – (2.4 %) Jamieson Brands Six months ended June 30 2025 2024 $ Change % Change Revenue 308,698 271,135 37,563 13.9 % Gross profit 132,041 102,414 29,627 28.9 % Labour relations costs (1) – 4,667 (4,667 ) (100.0 %) IT system implementation (4) 1,023 – 1,023 100.0 % Acquisition and divestiture related costs (2) – 165 (165 ) (100.0 %) Normalized gross profit 133,064 107,246 25,818 24.1 % Gross profit margin 42.8 % 37.8 % – 5.0 % Normalized gross profit margin 43.1 % 39.6 % – 3.5 % Share-based compensation (3) 4,165 3,493 672 19.2 % Selling, general and administrative expenses 101,807 80,323 21,484 26.7 % Acquisition and divestiture related costs (2) – (324 ) 324 100.0 % IT system implementation (4) (8,082 ) (6,429 ) (1,653 ) (25.7 %) Labour relations costs (1) – (1,721 ) 1,721 100.0 % Donations (5) (3,118 ) – (3,118 ) (100.0 %) Legal and other (6) (882 ) (297 ) (585 ) (197.0 %) Normalized selling, general and administrative expenses 89,725 71,552 18,173 25.4 % Earnings from operations 26,069 18,598 7,471 40.2 % Acquisition and divestiture related costs (2) – 489 (489 ) (100.0 %) IT system implementation (4) 9,105 6,429 2,676 41.6 % Labour relations costs (1) – 6,388 (6,388 ) (100.0 %) Donations (5) 3,118 – 3,118 100.0 % Legal and other (6) 882 297 585 197.0 % Normalized earnings from operations 39,174 32,201 6,973 21.7 % Operating margin 8.4 % 6.9 % – 1.5 % Normalized operating margin 12.7 % 11.9 % – 0.8 % Adjusted EBITDA 51,728 43,815 7,913 18.1 % Adjusted EBITDA margin 16.8 % 16.2 % – 0.6 % Strategic Partners Six months ended June 30 2025 2024 $ Change % Change Revenue 36,374 41,709 (5,335 ) (12.8 %) Gross profit 3,993 5,399 (1,406 ) (26.0 %) IT system implementation (4) 226 – 226 100.0 % Normalized gross profit 4,219 5,399 (1,180 ) (21.9 %) Gross profit margin 11.0 % 12.9 % – (1.9 %) Normalized gross profit margin 11.6 % 12.9 % – (1.3 %) Selling, general and administrative expenses 3,126 3,102 24 0.8 % Earnings from operations 867 2,297 (1,430 ) (62.3 %) IT system implementation (4) 226 – 226 100.0 % Normalized earnings from operations 1,093 2,297 (1,204 ) (52.4 %) Operating margin 2.4 % 5.5 % – (3.1 %) Normalized operating margin 3.0 % 5.5 % – (2.5 %) Adjusted EBITDA 2,438 3,837 (1,399 ) (36.5 %) Adjusted EBITDA margin 6.7 % 9.2 % – (2.5 %) Article content Reconciliation of Non-IFRS Financial Measures In thousands of Canadian dollars Three months ended Six months ended June 30 June 30 2025 2024 2025 2024 Net earnings: 13,828 8,313 11,314 4,594 Add: Recovery of income taxes 5,385 4,516 3,761 3,392 Interest expense and other financing costs 4,771 4,647 9,679 9,520 Accretion on preferred shares 1,155 2,121 3,427 4,340 Depreciation of property, plant, and equipment 3,474 3,236 6,729 6,752 Amortization of intangible assets 1,505 1,525 3,005 2,909 Earnings before interest, taxes, depreciation, and amortization (EBITDA) 30,118 24,358 37,915 31,507 Share-based compensation (3) 2,078 1,744 4,165 3,493 Foreign exchange gain (1,749 ) (180 ) (1,245 ) (951 ) Labour relations costs (1) – 1,695 – 6,388 IT system implementation (4) 3,796 3,449 9,331 6,429 Acquisition and divestiture related costs (2) – 489 – – Donations (5) – – 3,118 – Legal and other (6) 857 – 882 297 Adjusted EBITDA 35,100 31,555 54,166 47,652 Recovery of income taxes (5,385 ) (4,516 ) (3,761 ) (3,392 ) Interest expense and other financing costs (4,771 ) (4,647 ) (9,679 ) (9,520 ) Depreciation of property, plant, and equipment (3,474 ) (3,236 ) (6,729 ) (6,752 ) Amortization of intangible assets (1,505 ) (1,525 ) (3,005 ) (2,909 ) Share-based compensation (3) (1,956 ) (1,622 ) (3,921 ) (3,249 ) Tax deduction from vesting of certain share-based awards (19 ) – (708 ) – Tax effect of normalization adjustments (723 ) (1,355 ) (3,148 ) (3,261 ) Adjusted net earnings 17,267 14,654 23,215 18,569 Three months ended Six months ended June 30 June 30 2025 2024 2025 2024 Gross profit 80,814 65,028 136,034 107,813 Labour relations costs (1) – 1,414 – 4,667 Acquisition and divestiture related costs (2) – 165 – 165 IT system implementation (4) – – 1,249 165 Normalized gross profit 80,814 66,607 137,283 112,645 Normalized gross profit margin 40.6 % 36.0 % 39.8 % 36.0 % Selling, general and administrative expenses 55,346 43,867 104,933 83,425 Acquisition and divestiture related costs (2) – (324 ) – (324 ) IT system implementation (4) (3,796 ) (3,449 ) (8,082 ) (6,429 ) Labour relations costs (1) – (281 ) – (1,721 ) Donations (5) – – (3,118 ) – Legal and other (6) (857 ) – (882 ) (297 ) Normalized selling, general and administrative expenses 50,693 39,813 92,851 74,654 Earnings from operations 23,390 19,417 26,936 20,895 Acquisition and divestiture related costs (2) – 489 – 489 IT system implementation (4) 3,796 3,449 9,331 6,429 Donations (5) – – 3,118 – Labour relations costs (1) – 1,695 – 6,388 Legal and other (6) 857 – 882 297 Normalized earnings from operations 28,043 25,050 40,267 34,498 Normalized operating margin 14.1 % 13.6 % 11.7 % 11.0 % Article content (1) These expenses are mainly comprised of third-party legal, security fees, unavoidable facility expenditures, customer fines and penalties, along with freight charges to expedite shipments to customers as it relates to a labour disruption in Q1 2024. (2) Prior year expenses mainly pertain to legal, consulting and integration costs associated with the acquisition and integration of our former distributor partner in China on April 28, 2023. (3) The Company's share-based compensation expense pertains to our long-term incentive plan (the 'LTIP') (refer to ' Share-based compensation'), with stock options, performance-based share units ('PSUs'), time-based restricted share units ('RSUs'), and deferred share units ('DSUs') expenses, along with associated payroll taxes. (4) Mainly pertains to development costs associated with our IT system implementation to augment our system infrastructure. Unlike other system improvement projects with costs capitalized, due to its cloud-based nature, these system implementation costs are expensed accordingly. (5) Include cash and in-kind donations to support communities adjacent to our Irvine, California facility impacted by the wildfires. Article content Article content Article content Article content Article content Contacts Article content Investor and Media Contact Information: Article content Jamieson Wellness Article content Article content Ruth Winker Article content Article content Article content
